MELD Calculator (Model for End-Stage Liver Disease)

How MELD Calculator (Model for End-Stage Liver Disease) Works?

The MELD 3.0 calculator estimates the severity of advanced liver disease and the approximate risk of death within 90 days. It uses total bilirubin, INR, serum creatinine, serum sodium, serum albumin, dialysis status, and sex at birth. Bilirubin and INR represent impaired liver clearance and clotting-factor production, creatinine reflects kidney dysfunction, sodium accounts for the prognostic effect of hyponatremia, and albumin reflects liver protein production.

The calculation uses natural logarithms of bilirubin, INR, and creatinine. Before applying the model, clinical MELD 3.0 calculations commonly constrain laboratory values to the model's validated ranges, use a creatinine value of 3.0 when dialysis has occurred at least twice during the previous 7 days, and apply a female-sex adjustment.

Here, F equals 1 for female sex at birth and 0 for male sex at birth; Bili is total bilirubin, Na is serum sodium, Cr is serum creatinine, and Alb is serum albumin. A higher score indicates greater short-term disease severity and generally greater transplant urgency. The calculator then associates the score with commonly published 90-day mortality categories:

These mortality percentages provide population-level context; the MELD 3.0 score is not a diagnosis and should not replace assessment by a liver specialist or transplant program.

Practical Use Cases

Hepatologists and gastroenterologists: Clinicians can enter current bilirubin, INR, creatinine, sodium, albumin, dialysis status, and sex at birth to obtain a structured MELD 3.0 estimate for monitoring advanced liver disease and discussing changes in transplant urgency.

Transplant teams: Transplant coordinators can use the score as a quick reference when reviewing laboratory results, identifying substantial changes in severity, and preparing patients for formal allocation or listing discussions under applicable regional policies.

Hospital and emergency clinicians: Physicians caring for patients with decompensated cirrhosis can use the calculator to summarize short-term risk while coordinating specialist consultation, repeat laboratory testing, and decisions about transfer to a center with liver expertise.

Patients and caregivers: Patients can use the calculator to understand how recent laboratory results influence an estimated MELD 3.0 score, but the result should be reviewed with the treating liver team because timing, complications, medications, and clinical examination also affect care decisions.

Medical educators and trainees: Students can use the calculator to see how worsening clotting impairment, kidney dysfunction, low sodium, low albumin, or dialysis can change a prognostic score and to connect the equation with the physiology of advanced liver disease.

Accuracy and Limitations

The calculator follows the published MELD 3.0 structure and provides a rounded severity score with commonly used population-based 90-day mortality categories, but it is only an estimate. Accuracy depends on recent, reliable laboratory results and correct reporting of dialysis within the preceding 7 days; acute kidney injury, infection, bleeding, anticoagulant therapy that alters INR, rapidly changing laboratory values, and clinical complications such as encephalopathy or refractory ascites may make the estimate less representative of current risk. The displayed risk categories are not individualized predictions, and transplant eligibility or priority may differ because official programs use current policies, additional clinical information, and sometimes updated scoring rules.

Quick Examples